|
|
Article: Fosamax Once Weekly Treatment Preferred Over Fosamax Once Daily by Nearly Nine out of Ten Postmenopausal Women with Osteoporosis, New Study Showed.
- Article from:
- Business Wire
- Article date:
- October 15, 2001
CopyrightCOPYRIGHT 2001 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health & Pharmaceutical Writers
PHOENIX--(BUSINESS WIRE)--Oct. 15, 2001
Simplifying medical therapy can be an important component of disease management for patients with chronic medical conditions, especially those who may be without symptoms, such as many patients with osteoporosis.
A new study that examined dosing preference and convenience found that nearly nine out of 10 postmenopausal women with osteoporosis preferred a 70 mg once-weekly dosing regimen of Fosamax(R) (alendronate sodium) over a 10 mg once-daily regimen of Fosamax.
Results of this study were reported here at the American Society for Bone and ...